Bone disease

Published on 01/03/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1135 times

38

Bone disease

The finding that a patient has hypercalcaemia or hypocalcaemia does not imply that there will be marked bone changes. Conversely, severe bone disease can occur whilst serum calcium levels appear quite normal. The main bone diseases are:

Bone metabolism

Bone is constantly being broken down and reformed in the process of bone remodelling (Fig 38.1). The clinician looking after patients with bone disease will certainly need to know to what extent bone is being broken down, and, indeed, if new bone is being made. Biochemical markers of bone resorption and bone formation can be useful in assessing the extent of disease, as well as monitoring treatment.

Hydroxyproline, from the breakdown of collagen, can be used to monitor bone resorption. However, urinary hydroxyproline is markedly influenced by dietary gelatin. Better markers of resorption are required. One candidate would seem to be another collagen degradation product: the fragments of the molecule containing the pyridinium cross-links. Deoxypyridinoline is one such cross-link that is specific for bone, and not metabolized or influenced by diet.

The activity of the enzyme alkaline phosphatase has traditionally been used as an indicator of bone turnover. The osteoblasts that lay down the collagen framework and the mineral matrix of bone have high activity of this enzyme. Increased osteoblastic activity is indicated by an elevated alkaline phosphatase activity in a serum specimen. Indeed, children who have active bone growth compared with adults have higher ‘normal’ alkaline phosphatase activity in serum. However, alkaline phosphatase is also produced by the cells lining the bile canaliculi and is a marker for cholestasis. The bone isoenzyme of alkaline phosphatase may be measured, but there is need for a more specific and more sensitive marker.

Osteocalcin meets some of these requirements. It is synthesized by osteoblasts and is an important non-collagenous constituent of bone. Not all of the osteocalcin that an osteoblast makes is incorporated into the bone matrix. Some is released into plasma, and provides a sensitive indicator of osteoblast activity. The test is available in specialized laboratories.

Common bone disorders

Osteomalacia and rickets

Osteomalacia is the name given to defective bone mineralization in adults (Fig 38.2). Rickets is characterized by defects of bone and cartilage mineralization in children. Vitamin D deficiency was once the most common reason for rickets and osteomalacia, but the addition of vitamin D to foodstuffs has reduced the condition except in the elderly or house-bound, the institutionalized, and in certain ethnic groups. Although elderly Asian women with a predominantly vegetarian diet are particularly at risk, it should be noted that there appears to be a resurgence of rickets and osteomalacia in the white population of lower socio-economic status, due to poor diet and limited exposure to sunlight. Vitamin D status can be assessed by measurement of the main circulating metabolite, 25-hydroxycholecalciferol, in a serum specimen. The metabolism of vitamin D is shown in Figure 38.3.

In severe osteomalacia due to vitamin D deficiency, serum calcium will fall, and there will be an appropriate increase in PTH secretion. Serum alkaline phosphatase activity will also be elevated.

The bony features of osteomalacia and rickets are also shared by other bone diseases (see later).

Other bone diseases

Examples include:

Diagnosis of these and other rare conditions may require help from specialized laboratories.

Biochemistry testing in calcium disorders or bone disease

The role of the routine biochemistry laboratory in diagnosis and treatment of patients with calcium disorders and bone disease is to provide measurements of calcium, albumin, phosphate and alkaline phosphatase in a serum specimen as first line tests. Follow-up tests that may be requested include:

Characteristic biochemistry profiles in some common bone diseases are shown in Table 38.1.

Table 38.1

Biochemical profiles in bone diseases

Disease Profile
Bone metastases Calcium may be high, low or normal
  Phosphate may be high, low or normal
  PTH is usually low
  Alkaline phosphatase may be elevated or normal
Osteomalacia/rickets Calcium will tend to be low, or may be clearly decreased
  PTH will be elevated
  25-hydroxycholecalciferol will be decreased if the disease is due to vitamin D deficiency
Paget’s disease Calcium is normal
  Alkaline phosphatase is grossly elevated
Osteoporosis Biochemistry is unremarkable
Renal osteodystrophy Calcium is decreased
  PTH is very high
Osteitis fibrosa cystica (primary hyperparathyroidism) Calcium is elevated
Phosphate is low or normal
PTH is increased, or clearly detectable and thus ‘inappropriate’ to the hypercalcaemia